TipRanks
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market
6Y4
Vicore Pharma Holding AB
RESEARCH TOOLSreports

Vicore Pharma Holding AB (6Y4) Ratios

3 Followers

Vicore Pharma Holding AB Ratios

DE:6Y4's free cash flow for Q2 2026 was kr1.00. For the 2026 fiscal year, DE:6Y4's free cash flow was decreased by kr and operating cash flow was kr-67.62. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 12.68 10.31 16.50 12.10 5.81
Quick Ratio
 12.68 10.31 16.50 12.10 5.81
Cash Ratio
 5.87 4.89 15.86 8.15 5.53
Solvency Ratio
 -6.58 -3.85 -2.26 -7.24 -5.82
Operating Cash Flow Ratio
 -6.24 -3.17 -2.26 -6.09 -6.46
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 849.86Mkr 1.10Bkr 1.13Bkr 453.15Mkr 220.87M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 <0.01
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 <0.01
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.09 1.11 1.07 1.09 1.17
Debt Service Coverage Ratio
 -53.72 -9.48 -20.80K -885.70 -35.73K
Interest Coverage Ratio
 -52.06 -9.03 -24.27K -898.06 -36.34K
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.04 0.21 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.79 1.21 6.94 1.05 0.90
Profitability Margins
Gross Profit Margin
80.97%100.00%100.00%0.00%0.00%
EBIT Margin
-13560.62%-12507.57%-154.45%0.00%0.00%
EBITDA Margin
-13560.62%-12507.57%-152.40%0.00%0.00%
Operating Profit Margin
-13141.91%-11905.82%-177.59%0.00%0.00%
Pretax Profit Margin
-12563.27%-12509.14%-154.45%0.00%0.00%
Net Profit Margin
-12569.75%-12509.14%-154.22%0.00%0.00%
Continuous Operations Profit Margin
-12565.45%-12509.14%-154.22%0.00%0.00%
Net Income Per EBT
100.05%100.00%99.85%99.88%99.87%
EBT Per EBIT
95.60%105.07%86.97%96.83%99.34%
Return on Assets (ROA)
-53.99%-39.15%-14.02%-62.46%-85.33%
Return on Equity (ROE)
-53.71%-43.59%-14.93%-68.28%-99.77%
Return on Capital Employed (ROCE)
-61.26%-41.26%-17.18%-70.37%-99.70%
Return on Invested Capital (ROIC)
-61.26%-41.20%-17.16%-70.28%-99.55%
Return on Tangible Assets
-53.99%-39.15%-14.02%-62.74%-106.86%
Earnings Yield
-17.66%-17.61%-8.86%-23.34%-22.93%
Efficiency Ratios
Receivables Turnover
 0.54 0.28 5.54 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 0.19 0.15
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 <0.01 0.09 0.00 0.00
Working Capital Turnover Ratio
 <0.01 <0.01 0.14 0.00 0.00
Cash Conversion Cycle
 680.47 1.32K 65.94 -1.91K -2.37K
Days of Sales Outstanding
 680.47 1.32K 65.94 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 1.91K 2.37K
Operating Cycle
 680.47 1.32K 65.94 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.62 -1.56 -0.73 -2.58 -4.15
Free Cash Flow Per Share
 -1.06 -1.57 -0.73 -4.65 -4.19
CapEx Per Share
 1.26 1.56 0.00 2.06 0.04
Free Cash Flow to Operating Cash Flow
 0.66 1.00 1.00 1.80 1.01
Dividend Paid and CapEx Coverage Ratio
 -1.28 -1.00 0.00 -1.25 -99.97
Capital Expenditure Coverage Ratio
 -1.28 -1.00 0.00 -1.25 -99.97
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 -4.61K
Operating Cash Flow to Sales Ratio
 -114.03 -98.10 -1.51 0.00 0.00
Free Cash Flow Yield
-10.53%-13.86%-8.66%-33.67%-24.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.26 -5.68 -11.27 -4.29 -4.36
Price-to-Sales (P/S) Ratio
 711.92 710.16 17.41 0.00 0.00
Price-to-Book (P/B) Ratio
 3.33 2.47 1.69 2.93 4.35
Price-to-Free Cash Flow (P/FCF) Ratio
 -9.49 -7.21 -11.54 -2.97 -4.15
Price-to-Operating Cash Flow Ratio
 -6.24 -7.24 -11.54 -5.34 -4.19
Price-to-Earnings Growth (PEG) Ratio
 -0.32 -0.03 0.15 0.22 0.71
Price-to-Fair Value
 3.33 2.47 1.69 2.93 4.35
Enterprise Value Multiple
 -4.46 -4.47 -4.49 -3.15 -3.50
Enterprise Value
 2.41B 2.13B 747.92M 998.89M 1.00B
EV to EBITDA
 -4.46 -4.47 -4.49 -3.15 -3.50
EV to Sales
 604.61 558.69 6.84 0.00 0.00
EV to Free Cash Flow
 -8.06 -5.68 -4.53 -2.23 -3.31
EV to Operating Cash Flow
 -5.30 -5.70 -4.53 -4.00 -3.34
Tangible Book Value Per Share
 3.03 4.57 5.01 4.69 3.06
Shareholders’ Equity Per Share
 3.03 4.57 5.01 4.72 4.00
Tax and Other Ratios
Effective Tax Rate
 >-0.01 0.00 <0.01 <0.01 <0.01
Revenue Per Share
 0.01 0.02 0.49 0.00 0.00
Net Income Per Share
 -1.78 -1.99 -0.75 -3.22 -3.99
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.93 1.00 1.00 0.97 1.00
Research & Development to Revenue
 108.57 102.27 2.28 0.00 0.00
SG&A to Revenue
 23.59 17.79 0.46 0.00 0.00
Stock-Based Compensation to Revenue
 -0.68 0.00 0.00 0.00 0.00
Income Quality
 0.91 0.78 0.85 0.80 1.03
Currency in SEK